RxSight, Inc. - Common Stock (RXST)
8.0000
-0.4600 (-5.44%)
NASDAQ · Last Trade: Jul 12th, 5:04 PM EDT
Detailed Quote
Previous Close | 8.460 |
---|---|
Open | 8.320 |
Bid | 8.000 |
Ask | 8.200 |
Day's Range | 7.850 - 8.497 |
52 Week Range | 6.320 - 58.23 |
Volume | 2,226,301 |
Market Cap | 271.86M |
PE Ratio (TTM) | -11.94 |
EPS (TTM) | -0.7 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,744,374 |
Chart
About RxSight, Inc. - Common Stock (RXST)
Rxsight Inc is a healthcare technology company that focuses on enhancing vision correction through its innovative approach to personalized refractive surgery. The company develops advanced systems that utilize sophisticated algorithms and proprietary software to optimize intraocular lenses for patients undergoing cataract surgery. By combining data-driven insights with precision eye care, Rxsight aims to improve visual outcomes for patients, ultimately advancing the standards of treatment in the ophthalmic field. Their commitment to personalized medicine is reflected in their ongoing research and development efforts to create more effective solutions for vision-related challenges. Read More
News & Press Releases
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · July 11, 2025
Law Offices of Howard G. Smith announces an investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · July 11, 2025
The Law Offices of Frank R. Cruz announces an investigation of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By The Law Offices of Frank R. Cruz · Via Business Wire · July 10, 2025
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 9, 2025
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · July 9, 2025
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 9, 2025
Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.
Via Benzinga · July 9, 2025
RxSight Inc. (RXST) shares plunged 34.32% in after-hours. The decline to $8.40 follows a downward revision of its 2025 revenue forecast.
Via Benzinga · July 9, 2025
Via Benzinga · July 8, 2025
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · July 8, 2025
ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced select preliminary financial results for the second quarter 2025 and revised full-year 2025 guidance. The Company will host a conference call on Tuesday, July 8, 2025, at 5:00 p.m. Eastern Time.
By RxSight, Inc. · Via GlobeNewswire · July 8, 2025
By RxSight, Inc. · Via GlobeNewswire · May 20, 2025
Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · May 19, 2025
Via Benzinga · May 19, 2025
Via Benzinga · May 9, 2025
ALISO VIEJO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended March 31, 2025.
By RxSight, Inc. · Via GlobeNewswire · May 7, 2025